Patel Kinnari 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
Patel Kinnari
See Remarks
Transactions
- Sale
Common Stock
2024-08-16$18.50/sh−3,989$73,812→ 396,983 total
Holdings
- 5,675(indirect: By Spouse)
Common Stock
- 104,927(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
- [F2]The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.